Inventor

KLEIN MICHEL H

CA124 patents

⚠️ This page may combine multiple inventors who share the name “KLEIN MICHEL H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KLEIN MICHEL H

CONNAUGHT LAB

Antigenically-marked non-infectious retrovirus-like particles

Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus

Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles

Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers

Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus

Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region

Nucleic acid molecules encoding non-infectious, non-replicating, HIV retrovirus-like particles containing heterologous antigenic anchor sequences

Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains

Tandem synthetic HIV-1 Peptides

Nucleic acids encoding for non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region

Nucleic acids encoding high molecular weight major outer membrane protein of moraxella

Tandem synthetic HIV-1 peptides

Tandem synthetic HIV-1 peptides

Tandem synthetic HIV-1 peptides

Genetic detoxification of pertussis toxin

Vectors for DNA immunization against cervical cancer

Nucleic acid respiratory syncytial virus vaccines

Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats

Non-infectious HIV particles lacking long terminal repeats

Analog of Haemophilus Hin47 with reduced protease activity

Analog of Haemophilus Hin47 with reduced protease activity

Analog of Haemophilus Hin47 with reduced protease activity

Analog of Haemophilus Hin47 with reduced protease activity

Analog of haemophilus HIN47 with reduced protease activity

Method of use of an analog of Haemophilus influenzae Hin47 with reduced protease activity

Analog of haemophilus hin47 with reduced protease activity

Analog of Haemophilus Hin47 with reduced protease activity

Analog of haemophilus Hin47 with reduced protease activity

Biodegradable targetable microparticle delivery system

Nucleic acid respiratory syncytial virus vaccines

Neisseria meningitidis capsular polysacchride conjugates

Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus

Modification of pertussis toxin

Modification of pertussis toxin

Modification of pertussis toxin

Tandem synthetic HIV-1 peptides

Modification of pertussis toxin

Nucleic acid respiratory syncytial virus vaccines

Tandem synthetic HIV-1 peptide

Tandem synthetic HIV-1 peptides

AVENTIS PASTEUR

Biodegradable targetable microparticle delivery system

Biodegradable targetable microparticle delivery system

Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region

Anigenically-marked non-infectious retrovirus-like particles

Nucleic acid respiratory syncytial virus vaccines

Diagnostic kits comprising genetically engineered human immunodeficiency virus-like particles containing heterologous antigenic markers

High molecular weight major outer membrane protein of moraxella

(unassigned)

Analog of haemophilus Hin47 with reduced protease activity

Analog of Haemophilus Hin47 with reduced protease activity

SANOFI PASTEUR LTD

Chimeric immunogens